Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000032652Phase 4Completed
Phase 4 trial of dexmedetomidine in cardiac disease (2 arms), sponsored by Guangdong Provincial People's Hospital Zhuhai Hospital. Primary endpoints: Interleukin-6, Tumor necrosis factor-alpha and 1 more. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000032652.